<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36923413</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease.</ArticleTitle><Pagination><StartPage>1050528</StartPage><MedlinePgn>1050528</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1050528</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1050528</ELocationID><Abstract><AbstractText Label="PURPOSE AND METHODS">B cell-activating factor (BAFF) contributes to the pathogenesis of autoimmune diseases including systemic lupus erythematosus (SLE). Although several anti-BAFF Abs and derivatives have been developed for the treatment of SLE, the specific sources of BAFF that sustain autoantibody (auto-Ab) producing cells have not been definitively identified. Using BAFF-RFP reporter mice, we identified major changes in BAFF-producing cells in two mouse spontaneous lupus models (<i>Tlr7</i> Tg mice and <i>Sle1</i>), and in a pristane-induced lupus (PIL) model.</AbstractText><AbstractText Label="RESULTS">First, we confirmed that similar to their wildtype <i>Tlr7</i> Tg and <i>Sle1</i> mice counterparts, BAFF-RFP <i>Tlr7</i> Tg mice and BAFF-RFP <i>Sle1</i> mice had increased BAFF serum levels, which correlated with increases in plasma cells and auto-Ab production. Next, using the RFP reporter, we defined which cells had dysregulated BAFF production. BAFF-producing neutrophils (Nphs), monocytes (MOs), cDCs, T cells and B cells were all expanded in the spleens of BAFF-RFP <i>Tlr7</i> Tg mice and BAFF-RFP <i>Sle1</i> mice compared to controls. Furthermore, Ly6C<sup>hi</sup> inflammatory MOs and T cells had significantly increased BAFF expression per cell in both spontaneous lupus models, while CD8<sup>-</sup> DCs up-regulated BAFF expression only in the <i>Tlr7</i> Tg mice. Similarly, pristane injection of BAFF-RFP mice induced increases in serum BAFF levels, auto-Abs, and the expansion of BAFF-producing Nphs, MOs, and DCs in both the spleen and peritoneal cavity. BAFF expression in MOs and DCs, in contrast to BAFF from Nphs, was required to maintain homeostatic and pristane-induced systemic BAFF levels and to sustain mature B cell pools in spleens and BMs. Although acting through different mechanisms, Nph, MO and DC sources of BAFF were each required for the development of auto-Abs in PIL mice.</AbstractText><AbstractText Label="CONCLUSIONS">Our findings underscore the importance of considering the relative roles of specific myeloid BAFF sources and B cell niches when developing treatments for SLE and other BAFF-associated autoimmune diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Giordano, Kuley, Draves, Elkon, Giltiay and Clark.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuley</LastName><ForeName>Runa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Draves</LastName><ForeName>Kevin E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkon</LastName><ForeName>Keith B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giltiay</LastName><ForeName>Natalia V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Edward A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>26HZV48DT1</RegistryNumber><NameOfSubstance UI="C009042">pristane</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051199">Toll-Like Receptor 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505720">Tnfsf13b protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051199" MajorTopicYN="N">Toll-Like Receptor 7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">BAFF</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">dendritic cells</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword><Keyword MajorTopicYN="N">neutrophils</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>2</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36923413</ArticleId><ArticleId IdType="pmc">PMC10009188</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1050528</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol (2009) 9:491&#x2013;502. doi:&#xa0;10.1038/nri2572</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2572</ArticleId><ArticleId IdType="pubmed">19521398</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF/APRIL system: Emerging functions beyond b cell biology and autoimmunity. Cytokine Growth Factor Rev (2013) 24:203&#x2013;15. doi:&#xa0;10.1016/j.cytogfr.2013.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2013.04.003</ArticleId><ArticleId IdType="pmc">PMC7108297</ArticleId><ArticleId IdType="pubmed">23684423</ArticleId></ArticleIdList></Reference><Reference><Citation>Goenka R, Scholz JL, Sindhava VJ, Cancro MP. New roles for the BLyS/BAFF family in antigen-experienced b cell niches. Cytokine Growth Factor Rev (2014) 25:107&#x2013;13. doi:&#xa0;10.1016/j.cytogfr.2014.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC3999179</ArticleId><ArticleId IdType="pubmed">24507939</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami M, Schneider P. Function, occurrence and inhibition of different forms of BAFF. Curr Opin Immunol (2021) 71:75&#x2013;80. doi:&#xa0;10.1016/j.coi.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2021.06.009</ArticleId><ArticleId IdType="pubmed">34182216</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay F, Figgett WA, Saulep D, Lepage M, Hibbs ML. B-cell stage and context-dependent requirements for survival signals from BAFF and the b-cell receptor. Immunol Rev (2010) 237:205&#x2013;25. doi:&#xa0;10.1111/j.1600-065X.2010.00944.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2010.00944.x</ArticleId><ArticleId IdType="pubmed">20727038</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulski CR, Eibel H. BAFF and BAFF-receptor in b cell selection and survival. Front Immunol (2018) 9:2285. doi:&#xa0;10.3389/fimmu.2018.02285</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02285</ArticleId><ArticleId IdType="pmc">PMC6186824</ArticleId><ArticleId IdType="pubmed">30349534</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighoffer E, Tybulewicz VL. BAFF signaling in health and disease. Curr Opin Immunol (2021) 71:124&#x2013;31. doi:&#xa0;10.1016/j.coi.2021.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2021.06.014</ArticleId><ArticleId IdType="pubmed">34352467</ArticleId></ArticleIdList></Reference><Reference><Citation>Borhis G, Trovato M, Chaoul N, Ibrahim HM, Richard Y. B-Cell-Activating factor and the b-cell compartment in HIV/SIV infection. Front Immunol (2017) 8:1338. doi:&#xa0;10.3389/fimmu.2017.01338</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01338</ArticleId><ArticleId IdType="pmc">PMC5663724</ArticleId><ArticleId IdType="pubmed">29163465</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano D, Draves KE, Young LB, Roe K, Bryan MA, Dresch C, et al. . Protection of mice deficient in mature b cells from West Nile virus infection by passive and active immunization. PloS Pathog (2017) 13:e1006743. doi:&#xa0;10.1371/journal.ppat.1006743</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006743</ArticleId><ArticleId IdType="pmc">PMC5720816</ArticleId><ArticleId IdType="pubmed">29176765</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano D, Kuley R, Draves KE, Roe K, Holder U, Giltiay NV, et al. . BAFF produced by neutrophils and dendritic cells is regulated differently and has distinct roles in antibody responses and protective immunity against West Nile virus. J Immunol (2020) 204:1508&#x2013;20. doi:&#xa0;10.4049/jimmunol.1901120</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1901120</ArticleId><ArticleId IdType="pmc">PMC7357242</ArticleId><ArticleId IdType="pubmed">32034064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuley R, Draves KE, Fuller DH, Giltiay NV, Clark EA, Giordano D. B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective b cell responses against salmonella typhimurium infection. PloS One (2021) 16:e0259158. doi:&#xa0;10.1371/journal.pone.0259158</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259158</ArticleId><ArticleId IdType="pmc">PMC8550399</ArticleId><ArticleId IdType="pubmed">34705890</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai J, Akkoyunlu M. The role of BAFF system molecules in host response to pathogens. Clin Microbiol Rev (2017) 30:991&#x2013;1014. doi:&#xa0;10.1128/CMR.00046-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00046-17</ArticleId><ArticleId IdType="pmc">PMC5608883</ArticleId><ArticleId IdType="pubmed">28855265</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneparth A, Davidson A. B-cell activating factor targeted therapy and lupus. Arthritis Res Ther (2012) 14:1&#x2013;8. doi:&#xa0;10.1186/ar3920</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3920</ArticleId><ArticleId IdType="pmc">PMC3535720</ArticleId><ArticleId IdType="pubmed">23281926</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol (2014) 10:365&#x2013;73. doi:&#xa0;10.1038/nrrheum.2014.33</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2014.33</ArticleId><ArticleId IdType="pubmed">24614588</ArticleId></ArticleIdList></Reference><Reference><Citation>Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol (2017) 36:3&#x2013;19. doi:&#xa0;10.1080/08830185.2016.1276903</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2016.1276903</ArticleId><ArticleId IdType="pubmed">28215100</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabgah AG, Shariati-Sarabi Z, Tavakkol-Afshari J, Mohammadi M. The role of BAFF and APRIL in rheumatoid arthritis. J Cell Physiol (2019) 234:17050&#x2013;63. doi:&#xa0;10.1002/jcp.28445</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28445</ArticleId><ArticleId IdType="pubmed">30941763</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocturne G, Mariette X. B cells in the pathogenesis of primary sj&#xf6;gren syndrome. Nat Rev Rheumatol (2018) 14:133&#x2013;45. doi:&#xa0;10.1038/nrrheum.2018.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2018.1</ArticleId><ArticleId IdType="pubmed">29416129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanges S, Guerrier T, Launay D, Lef&#xe8;vre G, Labalette M, Forestier A, et al. . Role of b cells in the pathogenesis of systemic sclerosis. Rev M&#xe9;decine Interne (2017) 38:113&#x2013;24. doi:&#xa0;10.1016/j.revmed.2016.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.revmed.2016.02.016</ArticleId><ArticleId IdType="pubmed">27020403</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;ckel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE). Autoimmun Rev (2021) 20:102736. doi:&#xa0;10.1016/j.autrev.2020.102736</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102736</ArticleId><ArticleId IdType="pubmed">33333233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. . TACI and BCMA are receptors for a TNF homologue implicated in b-cell autoimmune disease. Nature (2000) 404:995&#x2013;9. doi:&#xa0;10.1038/35010115</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35010115</ArticleId><ArticleId IdType="pubmed">10801128</ArticleId></ArticleIdList></Reference><Reference><Citation>Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, et al. . BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med (2007) 204:1959&#x2013;71. doi:&#xa0;10.1084/jem.20062567</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20062567</ArticleId><ArticleId IdType="pmc">PMC2118661</ArticleId><ArticleId IdType="pubmed">17664289</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, et al. . Association of plasma b lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum (2008) 58:2453&#x2013;9. doi:&#xa0;10.1002/art.23678</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23678</ArticleId><ArticleId IdType="pubmed">18668552</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar-Camarena DC, Ortiz-Lazareno PC, Cruz A, Oregon-Romero E, Machado-Contreras JR, Mu&#xf1;oz-Valle JF, et al. . Association of BAFF, APRIL serum levels, BAFF-r, TACI and BCMA expression on peripheral b-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus (2016) 25:582&#x2013;92. doi:&#xa0;10.1177/0961203315608254</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315608254</ArticleId><ArticleId IdType="pubmed">26424128</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollars E, Bienkowska J, Czerkowicz J, Allaire N, Ranger AM, Magder L, et al. . BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year. Lupus Sci Med (2015) 2:e000063. doi:&#xa0;10.1136/lupus-2014-000063</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000063</ArticleId><ArticleId IdType="pmc">PMC4477150</ArticleId><ArticleId IdType="pubmed">26113988</ArticleId></ArticleIdList></Reference><Reference><Citation>Friebus-Kardash J, Trendelenburg M, Eisenberger U, Ribi C, Chizzolini C, Huynh-Do U, et al. . Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis. BMC Nephrol (2019) 20:1&#x2013;10. doi:&#xa0;10.1186/s12882-019-1623-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-019-1623-4</ArticleId><ArticleId IdType="pmc">PMC6873527</ArticleId><ArticleId IdType="pubmed">31752784</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent FB, Morand EF, Mackay F. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol (2012) 90:293&#x2013;303. doi:&#xa0;10.1038/icb.2011.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2011.111</ArticleId><ArticleId IdType="pubmed">22231653</ArticleId></ArticleIdList></Reference><Reference><Citation>Stohl W. Inhibition of b cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE). Expert Rev Clin Immunol (2017) 13:623&#x2013;33. doi:&#xa0;10.1080/1744666X.2017.1291343</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2017.1291343</ArticleId><ArticleId IdType="pubmed">28164726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SW, Davidson A. BAFF inhibition in SLE&#x2013;is tolerance restored? Immunol Rev (2019) 292:102&#x2013;19. doi:&#xa0;10.1111/imr.12810</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12810</ArticleId><ArticleId IdType="pmc">PMC6935406</ArticleId><ArticleId IdType="pubmed">31562657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WS, Amengual O. B cells targeting therapy in the management of systemic lupus erythematosus. Immunol Med (2020) 43:16&#x2013;35. doi:&#xa0;10.1080/25785826.2019.1698929</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/25785826.2019.1698929</ArticleId><ArticleId IdType="pubmed">32107989</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin W, Lee HT, Lim H, Lee SH, Son JY, Lee JU, et al. . BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus. Nat Commun (2018) 9:1200. doi:&#xa0;10.1038/s41467-018-03620-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03620-2</ArticleId><ArticleId IdType="pmc">PMC5865148</ArticleId><ArticleId IdType="pubmed">29572471</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, et al. . Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity (2007) 27:801&#x2013;10. doi:&#xa0;10.1016/j.immuni.2007.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.09.009</ArticleId><ArticleId IdType="pmc">PMC2706502</ArticleId><ArticleId IdType="pubmed">17997333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S-H, Lee H, Yamamoto M, Jones LA, Dayalan J, Hopkins R, et al. . B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus&#x2013;prone mice. J Immunol (2012) 189:5786&#x2013;96. doi:&#xa0;10.4049/jimmunol.1202195</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202195</ArticleId><ArticleId IdType="pmc">PMC3544945</ArticleId><ArticleId IdType="pubmed">23150717</ArticleId></ArticleIdList></Reference><Reference><Citation>Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal TH, Wiedeman AE, et al. . Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 b cells. J Exp Med (2013) 210:2773&#x2013;89. doi:&#xa0;10.1084/jem.20122798</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20122798</ArticleId><ArticleId IdType="pmc">PMC3832927</ArticleId><ArticleId IdType="pubmed">24145511</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L, Mohan C, Yu Y, Croker BP, Tian N, Deng A, et al. . Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol (1997) 158:6019&#x2013;28. doi: 10.4049/jimmunol.158.12.6019</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.158.12.6019</ArticleId><ArticleId IdType="pubmed">9190957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C, Alas E, Morel L, Yang P, Wakeland EK. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest (1998) 101:1362&#x2013;72. doi:&#xa0;10.1172/JCI728</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI728</ArticleId><ArticleId IdType="pmc">PMC508691</ArticleId><ArticleId IdType="pubmed">9502778</ArticleId></ArticleIdList></Reference><Reference><Citation>Buechler MB, Teal TH, Elkon KB, Hamerman JA. Cutting edge: Type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling. J Immunol (2013) 190:886&#x2013;91. doi:&#xa0;10.4049/jimmunol.1202739</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202739</ArticleId><ArticleId IdType="pmc">PMC3552021</ArticleId><ArticleId IdType="pubmed">23303674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;strand M, Johansson A, Aqrawi L, Olsson T, Wahren-Herlenius M, Espinosa A. The expression of BAFF is controlled by IRF transcription factors. J Immunol (2016) 196:91&#x2013;6. doi:&#xa0;10.4049/jimmunol.1501061</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501061</ArticleId><ArticleId IdType="pmc">PMC4683359</ArticleId><ArticleId IdType="pubmed">26590315</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, et al. . Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci (2000) 97:6670&#x2013;5. doi:&#xa0;10.1073/pnas.97.12.6670</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.12.6670</ArticleId><ArticleId IdType="pmc">PMC18697</ArticleId><ArticleId IdType="pubmed">10841565</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol (2009) 30:455&#x2013;64. doi:&#xa0;10.1016/j.it.2009.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.06.003</ArticleId><ArticleId IdType="pmc">PMC2746238</ArticleId><ArticleId IdType="pubmed">19699150</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, et al. . TLR7-dependent and Fc&#x3b3;R-independent production of type I interferon in experimental mouse lupus. J Exp Med (2008) 205:2995&#x2013;3006. doi:&#xa0;10.1084/jem.20080462</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20080462</ArticleId><ArticleId IdType="pmc">PMC2605237</ArticleId><ArticleId IdType="pubmed">19047436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PY, Li Y, Kumagai Y, Xu Y, Weinstein JS, Kellner ES, et al. . Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol (2009) 175:2023&#x2013;33. doi:&#xa0;10.2353/ajpath.2009.090328</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.090328</ArticleId><ArticleId IdType="pmc">PMC2774066</ArticleId><ArticleId IdType="pubmed">19808647</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano D, Draves KE, Li C, Hohl TM, Clark EA. Nitric oxide regulates BAFF expression and T cell&#x2013;independent antibody responses. J Immunol (2014) 193:1110&#x2013;20. doi:&#xa0;10.4049/jimmunol.1303158</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303158</ArticleId><ArticleId IdType="pmc">PMC4108544</ArticleId><ArticleId IdType="pubmed">24951820</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe K, Shu GL, Draves KE, Giordano D, Pepper M, Clark EA. Targeting antigens to CD180 but not CD40 programs immature and mature b cell subsets to become efficient APCs. J Immunol (2019) 203:1715&#x2013;29. doi:&#xa0;10.4049/jimmunol.1900549</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900549</ArticleId><ArticleId IdType="pmc">PMC6761014</ArticleId><ArticleId IdType="pubmed">31484732</ArticleId></ArticleIdList></Reference><Reference><Citation>Du SW, Jacobs HM, Arkatkar T, Rawlings DJ, Jackson SW. Integrated b cell, toll-like, and BAFF receptor signals promote autoantibody production by transitional b cells. J Immunol (2018) 201:3258&#x2013;68. doi:&#xa0;10.4049/jimmunol.1800393</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800393</ArticleId><ArticleId IdType="pmc">PMC6779322</ArticleId><ArticleId IdType="pubmed">30373855</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Wiedeman A, Agrawal N, Teal TH, Tanaka L, Hudkins KL, et al. . Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J Immunol (2013) 190:2536&#x2013;43. doi:&#xa0;10.4049/jimmunol.1202689</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202689</ArticleId><ArticleId IdType="pmc">PMC3594466</ArticleId><ArticleId IdType="pubmed">23382559</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Richards HB, Shaheen VM, Yoshida H, Shaw M, Naim JO, et al. . Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol (2000) 121:399&#x2013;405. doi:&#xa0;10.1046/j.1365-2249.2000.01276.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2000.01276.x</ArticleId><ArticleId IdType="pmc">PMC1905709</ArticleId><ArticleId IdType="pubmed">10931159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol (2014) 14:392&#x2013;404. doi:&#xa0;10.1038/nri3671</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3671</ArticleId><ArticleId IdType="pubmed">24854589</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol (2017) 17:349&#x2013;62. doi:&#xa0;10.1038/nri.2017.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.28</ArticleId><ArticleId IdType="pubmed">28436425</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhang Y, Pan G, Xiang L, Luo D, Shao J. Occurrences and functions of Ly6Chi and Ly6Clo macrophages in health and disease(2022) (Accessed November 7, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189283</ArticleId><ArticleId IdType="pubmed">35707538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal b cell homeostasis requires b cell activation factor production by radiation-resistant cells. J Exp Med (2003) 198:937&#x2013;45. doi:&#xa0;10.1084/jem.20030789</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20030789</ArticleId><ArticleId IdType="pmc">PMC2194202</ArticleId><ArticleId IdType="pubmed">12975458</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy G, Isenberg DA. New therapies for systemic lupus erythematosus &#x2014; past imperfect, future tense. Nat Rev Rheumatol (2019) 15:403. doi:&#xa0;10.1038/s41584-019-0235-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-019-0235-5</ArticleId><ArticleId IdType="pubmed">31165780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamin F, Vincent IE, Summerfield A, McCullough KC. Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol (2007) 37:3122&#x2013;30. doi:&#xa0;10.1002/eji.200636791</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200636791</ArticleId><ArticleId IdType="pubmed">17935087</ArticleId></ArticleIdList></Reference><Reference><Citation>Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al. . DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol (2002) 3:822. doi:&#xa0;10.1038/ni829</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni829</ArticleId><ArticleId IdType="pmc">PMC4621779</ArticleId><ArticleId IdType="pubmed">12154359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yang M, Long D, Li Q, Zhao M, Wu H, et al. . Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients. Autoimmunity (2020) 53:192&#x2013;200. doi:&#xa0;10.1080/08916934.2020.1736049</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2020.1736049</ArticleId><ArticleId IdType="pubmed">32157911</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto K, Takahashi Y, Ogasawara M, Setoyama Y, Suzuki K, Tsuzaka K, et al. . Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, loucy. Int Immunol (2006) 18:1189&#x2013;96. doi:&#xa0;10.1093/intimm/dxl053</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxl053</ArticleId><ArticleId IdType="pubmed">16740602</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, et al. . Expression of b-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent b cell pathogenic autoantibody production. Rheumatol Oxf Engl (2007) 46:1083&#x2013;6. doi:&#xa0;10.1093/rheumatology/kem097</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem097</ArticleId><ArticleId IdType="pubmed">17500077</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu VT, Enghard P, Riemekasten G, Berek C. In vitro and In vivo activation induces BAFF and APRIL expression in b cells. J Immunol (2007) 179:5947&#x2013;57. doi:&#xa0;10.4049/jimmunol.179.9.5947</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.9.5947</ArticleId><ArticleId IdType="pubmed">17947668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu VT, Enghard P, Sch&#xfc;rer S, Steinhauser G, Rudolph B, Riemekasten G, et al. . Systemic activation of the immune system induces aberrant BAFF and APRIL expression in b cells in patients with systemic lupus erythematosus. Arthritis Rheum (2009) 60:2083&#x2013;93. doi:&#xa0;10.1002/art.24628</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24628</ArticleId><ArticleId IdType="pubmed">19565488</ArticleId></ArticleIdList></Reference><Reference><Citation>Coquery CM, Loo WM, Wade NS, Bederman AG, Tung KS, Lewis JE, et al. . BAFF regulates follicular helper T cells and affects their accumulation and interferon-&#x3b3; production in autoimmunity. Arthritis Rheumatol (2015) 67:773&#x2013;84. doi:&#xa0;10.1002/art.38950</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38950</ArticleId><ArticleId IdType="pmc">PMC4342294</ArticleId><ArticleId IdType="pubmed">25385309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Skuginna V, Kulkarni OP, Gong J, Wei T, Stark RW, et al. . Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis. J Pathol (2010) 220:596&#x2013;607. doi:&#xa0;10.1002/path.2678</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2678</ArticleId><ArticleId IdType="pubmed">20112371</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Jiao Y, Cui B, Gao X, Xu J, Zhao Y. The potential protective role of hepatitis b virus infection in pristane-induced lupus in mice. Lupus (2016) 25:1180&#x2013;9. doi:&#xa0;10.1177/0961203316631637</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316631637</ArticleId><ArticleId IdType="pubmed">27125291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu A, Li H, Niu J, Wu S, Xue G, Yao X, et al. . Hyperactivation of the NLRP3 inflammasome in myeloid cells leads to severe organ damage in experimental lupus. J Immunol (2017) 198:1119&#x2013;29. doi:&#xa0;10.4049/jimmunol.1600659</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600659</ArticleId><ArticleId IdType="pubmed">28039299</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsa R, Lund H, Georgoudaki A-M, Zhang X-M, Guerreiro-Cacais AO, Grommisch D, et al. . BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med (2016) 213:1537&#x2013;53. doi:&#xa0;10.1084/jem.20150577</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150577</ArticleId><ArticleId IdType="pmc">PMC4986521</ArticleId><ArticleId IdType="pubmed">27432941</ArticleId></ArticleIdList></Reference><Reference><Citation>Scapini P, Carletto A, Nardelli B, Calzetti F, Roschke V, Merigo F, et al. . Proinflammatory mediators elicit secretion of the intracellular b-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases. Blood (2005) 105:830&#x2013;7. doi:&#xa0;10.1182/blood-2004-02-0564</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-02-0564</ArticleId><ArticleId IdType="pubmed">15358625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacionales DC, Kelly-Scumpia KM, Lee PY, Weinstein JS, Lyons R, Sobel E, et al. . Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum (2007) 56:3770&#x2013;83. doi:&#xa0;10.1002/art.23023</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23023</ArticleId><ArticleId IdType="pmc">PMC2909118</ArticleId><ArticleId IdType="pubmed">17968932</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C, Kaplan M. The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol (2015) 27:448&#x2013;53. doi:&#xa0;10.1097/BOR.0000000000000197</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000197</ArticleId><ArticleId IdType="pubmed">26125102</ArticleId></ArticleIdList></Reference><Reference><Citation>Stohl W, Jacob N, Guo S, Morel L. Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus&#x2013;like autoimmunity. Arthritis Rheum (2010) 62:2432&#x2013;42. doi:&#xa0;10.1002/art.27502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27502</ArticleId><ArticleId IdType="pmc">PMC2921019</ArticleId><ArticleId IdType="pubmed">20506216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B, et al. . BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum (2005) 52:2080&#x2013;91. doi:&#xa0;10.1002/art.21138</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21138</ArticleId><ArticleId IdType="pubmed">15986357</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Chen B, Liu X, Li H, Xie L, Gao Y, et al. . Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proc Natl Acad Sci (2021) 118:e2023216118. doi:&#xa0;10.1073/pnas.2023216118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2023216118</ArticleId><ArticleId IdType="pmc">PMC8379935</ArticleId><ArticleId IdType="pubmed">34385315</ArticleId></ArticleIdList></Reference><Reference><Citation>Coquery CM, Wade NS, Loo WM, Kinchen JM, Cox KM, Jiang C, et al. . Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and b cell responses in lupus-prone mice. PloS One (2014) 9:e102284. doi:&#xa0;10.1371/journal.pone.0102284</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102284</ArticleId><ArticleId IdType="pmc">PMC4092127</ArticleId><ArticleId IdType="pubmed">25010693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird AK, Chang M, Barnard J, Goldman BI, Meednu N, Rangel-Moreno J, et al. . Neutrophils slow disease progression in murine lupus via modulation of autoreactive germinal centers. J Immunol (2017) 199:458&#x2013;66. doi:&#xa0;10.4049/jimmunol.1700354</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700354</ArticleId><ArticleId IdType="pmc">PMC5524201</ArticleId><ArticleId IdType="pubmed">28584005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresneda Alarcon M, McLaren Z, Wright HL. Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: Same foe different M.O(2021) (Accessed February 2, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969658</ArticleId><ArticleId IdType="pubmed">33746988</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Liu X, Zhang Y, Wang Z, Zhu G, Han G, et al. . Interleukin (IL)-39 [IL-23p19/Epstein&#x2013;Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice. Clin Exp Immunol (2016) 186:144&#x2013;56. doi:&#xa0;10.1111/cei.12840</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12840</ArticleId><ArticleId IdType="pmc">PMC5054574</ArticleId><ArticleId IdType="pubmed">27400195</ArticleId></ArticleIdList></Reference><Reference><Citation>Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, et al. . B cell&#x2013;helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol (2012) 13:170&#x2013;80. doi:&#xa0;10.1038/ni.2194</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2194</ArticleId><ArticleId IdType="pmc">PMC3262910</ArticleId><ArticleId IdType="pubmed">22197976</ArticleId></ArticleIdList></Reference><Reference><Citation>Deniset JF, Surewaard BG, Lee W-Y, Kubes P. Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of s. pneumoniae. J Exp Med (2017) 214:1333&#x2013;50. doi:&#xa0;10.1084/jem.20161621</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161621</ArticleId><ArticleId IdType="pmc">PMC5413339</ArticleId><ArticleId IdType="pubmed">28424248</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremic I, Djuric O, Nikolic M, Vlajnic M, Nikolic A, Radojkovic D, et al. . Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus. Rheumatol Int (2019) 39:1849&#x2013;57. doi:&#xa0;10.1007/s00296-019-04426-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-019-04426-1</ArticleId><ArticleId IdType="pubmed">31444555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PY, Weinstein JS, Nacionales DC, Scumpia PO, Li Y, Butfiloski E, et al. . A novel type I IFN-producing cell subset in murine lupus. J Immunol (2008) 180:5101&#x2013;8. doi:&#xa0;10.4049/jimmunol.180.7.5101</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.7.5101</ArticleId><ArticleId IdType="pmc">PMC2909121</ArticleId><ArticleId IdType="pubmed">18354236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood (2006) 108:2687&#x2013;94. doi:&#xa0;10.1182/blood-2005-12-017319</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-12-017319</ArticleId><ArticleId IdType="pmc">PMC1895592</ArticleId><ArticleId IdType="pubmed">16825497</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon S-T, Kim W-J, Lee S-M, Lee M-Y, Park S-B, Lee S-H, et al. . Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol Cell Biol (2010) 88:148&#x2013;56. doi:&#xa0;10.1038/icb.2009.75</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2009.75</ArticleId><ArticleId IdType="pubmed">19841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, He D, Chen Q, Guo X, Yang L, Lin X, et al. . BAFF is involved in macrophage-induced bortezomib resistance in myeloma. Cell Death Dis (2017) 8:e3161&#x2013;1. doi:&#xa0;10.1038/cddis.2017.533</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.533</ArticleId><ArticleId IdType="pmc">PMC5775406</ArticleId><ArticleId IdType="pubmed">29095438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto K, Suzuki K, Takei E, Ikeda Y, Takeuchi T. Elevated expression of BAFF receptor, BR3, on monocytes correlates with b cell activation and clinical features of patients with primary sj&#xf6;gren&#x2019;s syndrome. Arthritis Res Ther (2020) 22:1&#x2013;10. doi:&#xa0;10.1186/s13075-020-02249-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02249-1</ArticleId><ArticleId IdType="pmc">PMC7310340</ArticleId><ArticleId IdType="pubmed">32576236</ArticleId></ArticleIdList></Reference><Reference><Citation>Porat A, Giat E, Kowal C, He M, Son M, Latz E, et al. . DNA-Mediated interferon signature induction by SLE serum occurs in monocytes through two pathways: A mechanism to inhibit both pathways(2018) (Accessed November 2, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6297782</ArticleId><ArticleId IdType="pubmed">30619247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Xu S, Li X, Wang B, Wang X, Ma D, et al. . Pathway of toll-like receptor 7/B cell activating Factor/B cell activating factor receptor plays a role in immune thrombocytopenia. In Vivo. PloS One (2011) 6:e22708. doi:&#xa0;10.1371/journal.pone.0022708</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022708</ArticleId><ArticleId IdType="pmc">PMC3144916</ArticleId><ArticleId IdType="pubmed">21818370</ArticleId></ArticleIdList></Reference><Reference><Citation>Celhar T, Lu HK, Benso L, Rakhilina L, Lee HY, Tripathi S, et al. . TLR7 protein expression in mild and severe lupus-prone models is regulated in a leukocyte, genetic, and IRAK4 dependent manner(2019) (Accessed January 27, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636428</ArticleId><ArticleId IdType="pubmed">31354711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram U, Varghese L, Bennett HL, Jog NR, Shivers DK, Ning Y, et al. . Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J Immunol (2012) 189:80&#x2013;91. doi:&#xa0;10.4049/jimmunol.1101686</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1101686</ArticleId><ArticleId IdType="pmc">PMC3381850</ArticleId><ArticleId IdType="pubmed">22661089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-Y, Kumar R, Iida R, Bagavant H, Alarc&#xf3;n-Riquelme ME. BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation. PloS One (2016) 11:e0156302. doi:&#xa0;10.1371/journal.pone.0156302</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156302</ArticleId><ArticleId IdType="pmc">PMC4882053</ArticleId><ArticleId IdType="pubmed">27228057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang N-H, Cheung Y-H, Loh C, Pau E, Roy V, Cai Y-C, et al. . B cell activating factor (BAFF) and T cells cooperate to breach b cell tolerance in lupus-prone new Zealand black (NZB) mice. PloS One (2010) 5:e11691. doi:&#xa0;10.1371/journal.pone.0011691</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011691</ArticleId><ArticleId IdType="pmc">PMC2908288</ArticleId><ArticleId IdType="pubmed">20661465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Roschke V, Baker KP, Wang Z, Alarc&#xf3;n GS, Fessler BJ, et al. . Cutting edge: A role for b lymphocyte stimulator in systemic lupus erythematosus. J Immunol (2001) 166:6&#x2013;10. doi:&#xa0;10.4049/jimmunol.166.1.6</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.1.6</ArticleId><ArticleId IdType="pubmed">11123269</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy EM, Lee RZ, N&#xed; Gabhann J, Smith S, Cunnane G, Doran MF, et al. . Elevated b lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort. Rheumatology (2013) 52:1279&#x2013;84. doi:&#xa0;10.1093/rheumatology/ket120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket120</ArticleId><ArticleId IdType="pubmed">23479724</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan JH, Jiang Y, Mu H, Tang ZQ. Expression of BAFF and BR3 in patients with systemic lupus erythematosus. Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol (2016) 49. doi:&#xa0;10.1590/1414-431X20154853</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431X20154853</ArticleId><ArticleId IdType="pmc">PMC4763815</ArticleId><ArticleId IdType="pubmed">26840704</ArticleId></ArticleIdList></Reference><Reference><Citation>Giltiay NV, Giordano D, Clark EA. The plasticity of newly formed b cells. J Immunol (2019) 203:3095&#x2013;104. doi:&#xa0;10.4049/jimmunol.1900928</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900928</ArticleId><ArticleId IdType="pmc">PMC6961804</ArticleId><ArticleId IdType="pubmed">31818922</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs HM, Thouvenel CD, Leach S, Arkatkar T, Metzler G, Scharping NE, et al. . Cutting edge: BAFF promotes autoantibody production via TACI-dependent activation of transitional b cells. J Immunol (2016) 196:3525&#x2013;31. doi:&#xa0;10.4049/jimmunol.1600017</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600017</ArticleId><ArticleId IdType="pmc">PMC4868625</ArticleId><ArticleId IdType="pubmed">27022196</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossenk&#xe4;mper A, Lutalo PMK, Spencer J. Translational mini-review series on b cell subsets in disease. transitional b cells in systemic lupus erythematosus and sj&#xf6;gren&#x2019;s syndrome: clinical implications and effects of b cell-targeted therapies. Clin Exp Immunol (2012) 167:7&#x2013;14. doi:&#xa0;10.1111/j.1365-2249.2011.04460.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04460.x</ArticleId><ArticleId IdType="pmc">PMC3248081</ArticleId><ArticleId IdType="pubmed">22132879</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawlings DJ, Metzler G, Wray-Dutra M, Jackson SW. Altered b cell signalling in autoimmunity. Nat Rev Immunol (2017) 17:421&#x2013;36. doi:&#xa0;10.1038/nri.2017.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.24</ArticleId><ArticleId IdType="pmc">PMC5523822</ArticleId><ArticleId IdType="pubmed">28393923</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez P, Scheel-Toellner D, Rodr&#xed;guez-Carrio J, Caminal-Montero L, Gordon C, Su&#xe1;rez A. Interferon-&#x3b1;-induced b-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes. Rheumatology (2014) 53:2249&#x2013;58. doi:&#xa0;10.1093/rheumatology/keu249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu249</ArticleId><ArticleId IdType="pubmed">24942493</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo H, Coquery C, Xue Y, Gayet I, Dillon SR, Punaro M, et al. . Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J Exp Med (2012) 209:1335&#x2013;48. doi:&#xa0;10.1084/jem.20111644</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111644</ArticleId><ArticleId IdType="pmc">PMC3405503</ArticleId><ArticleId IdType="pubmed">22689824</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyagawa F, Tagaya Y, Ozato K, Horie K, Asada H. Inflammatory monocyte-derived dendritic cells mediate autoimmunity in murine model of systemic lupus erythematosus. J Transl Autoimmun (2020) 3:100060. doi:&#xa0;10.1016/j.jtauto.2020.100060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100060</ArticleId><ArticleId IdType="pmc">PMC7388367</ArticleId><ArticleId IdType="pubmed">32743540</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, Malvar A, Shapiro J, Turman JM, Song H, Alberton V, et al. . A novel inflammatory dendritic cell that is abundant and contiguous to T cells in the kidneys of patients with lupus nephritis(2021) (Accessed November 2, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919935</ArticleId><ArticleId IdType="pubmed">33659005</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Fan W, Jensen MA, Dorschner JM, Bonadurer GF, Vsetecka DM, et al. . Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy. Lupus Sci Med (2017) 4:e000202. doi:&#xa0;10.1136/lupus-2016-000202</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000202</ArticleId><ArticleId IdType="pmc">PMC5724340</ArticleId><ArticleId IdType="pubmed">29238602</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Maurer K, Perin JC, Song L, Sullivan KE. Cytokine-induced monocyte characteristics in SLE. BioMed Res Int (2010) 2010:e507475. doi:&#xa0;10.1155/2010/507475</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/507475</ArticleId><ArticleId IdType="pmc">PMC2896681</ArticleId><ArticleId IdType="pubmed">20625490</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Kaplan MJ. Bite of the wolf: innate immune responses propagate autoimmunity in lupus. J Clin Invest (2021) 131:e144918. doi:&#xa0;10.1172/JCI144918</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI144918</ArticleId><ArticleId IdType="pmc">PMC7843222</ArticleId><ArticleId IdType="pubmed">33529160</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiteras J, Ripoll &#xc9;, Bola&#xf1;os N, De Ramon L, Fontova P, Lloberas N, et al. . The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis. Mol Ther - Nucleic Acids (2021) 24:807&#x2013;21. doi:&#xa0;10.1016/j.omtn.2021.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8105598</ArticleId><ArticleId IdType="pubmed">33996261</ArticleId></ArticleIdList></Reference><Reference><Citation>Castenmiller C, Keumatio-Doungtsop B-C, van Ree R, de Jong EC, van Kooyk Y. Tolerogenic immunotherapy: Targeting DC surface receptors to induce antigen-specific tolerance(2021) (Accessed November 30, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933040</ArticleId><ArticleId IdType="pubmed">33679806</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes-Rius A, Desai A, Yuen D, Johnston APR, Voelcker NH. Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nat Nanotechnol (2021) 16:37&#x2013;46. doi:&#xa0;10.1038/s41565-020-00810-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-020-00810-2</ArticleId><ArticleId IdType="pubmed">33349685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwant LE, Vegting Y, Tsang-a-Sjoe MWP, Kwakernaak AJ, Vogt L, Voskuyl AE, et al. . Macrophages in lupus nephritis: Exploring a potential new therapeutic avenue. Autoimmun Rev (2022) 21:103211. doi:&#xa0;10.1016/j.autrev.2022.103211</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103211</ArticleId><ArticleId IdType="pubmed">36252930</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>